228 related articles for article (PubMed ID: 33866453)
1. Bone Morphogenic Protein Signaling and Melanoma.
Kraj P
Curr Treat Options Oncol; 2021 Apr; 22(6):48. PubMed ID: 33866453
[TBL] [Abstract][Full Text] [Related]
2. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
3. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
[TBL] [Abstract][Full Text] [Related]
4. Canonical Wnt and TGF-β/BMP signaling enhance melanocyte regeneration but suppress invasiveness, migration, and proliferation of melanoma cells.
Katkat E; Demirci Y; Heger G; Karagulle D; Papatheodorou I; Brazma A; Ozhan G
Front Cell Dev Biol; 2023; 11():1297910. PubMed ID: 38020918
[TBL] [Abstract][Full Text] [Related]
5. Developmental pathways activated in melanocytes and melanoma.
Liu J; Fukunaga-Kalabis M; Li L; Herlyn M
Arch Biochem Biophys; 2014 Dec; 563():13-21. PubMed ID: 25109840
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice.
Wehbe M; Soudja SM; Mas A; Chasson L; Guinamard R; de Tenbossche CP; Verdeil G; Van den Eynde B; Schmitt-Verhulst AM
PLoS One; 2012; 7(11):e49419. PubMed ID: 23173060
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic proteins in melanoma: angel or devil?
Hsu MY; Rovinsky S; Penmatcha S; Herlyn M; Muirhead D
Cancer Metastasis Rev; 2005 Jun; 24(2):251-63. PubMed ID: 15986135
[TBL] [Abstract][Full Text] [Related]
9. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
Caramel J; Papadogeorgakis E; Hill L; Browne GJ; Richard G; Wierinckx A; Saldanha G; Osborne J; Hutchinson P; Tse G; Lachuer J; Puisieux A; Pringle JH; Ansieau S; Tulchinsky E
Cancer Cell; 2013 Oct; 24(4):466-80. PubMed ID: 24075834
[TBL] [Abstract][Full Text] [Related]
10. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
12. Regulation of epithelial to mesenchymal transition by bone morphogenetic proteins.
McCormack N; O'Dea S
Cell Signal; 2013 Dec; 25(12):2856-62. PubMed ID: 24044921
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic proteins induce expression of metalloproteinases in melanoma cells and fibroblasts.
Rothhammer T; Braig S; Bosserhoff AK
Eur J Cancer; 2008 Nov; 44(16):2526-34. PubMed ID: 18774289
[TBL] [Abstract][Full Text] [Related]
14. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling.
Garulli C; Kalogris C; Pietrella L; Bartolacci C; Andreani C; Falconi M; Marchini C; Amici A
Cell Signal; 2014 Feb; 26(2):352-62. PubMed ID: 24280125
[TBL] [Abstract][Full Text] [Related]
15. Signaling mechanisms of the epithelial-mesenchymal transition.
Gonzalez DM; Medici D
Sci Signal; 2014 Sep; 7(344):re8. PubMed ID: 25249658
[TBL] [Abstract][Full Text] [Related]
16. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
Hsiao JJ; Fisher DE
Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
[TBL] [Abstract][Full Text] [Related]
17. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
[TBL] [Abstract][Full Text] [Related]
18. Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.
Xiao D; Barry S; Kmetz D; Egger M; Pan J; Rai SN; Qu J; McMasters KM; Hao H
Cancer Lett; 2016 Jul; 376(2):318-27. PubMed ID: 27063098
[TBL] [Abstract][Full Text] [Related]
19. Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy.
Kuczma M; Kurczewska A; Kraj P
J Immunotoxicol; 2014 Oct; 11(4):319-27. PubMed ID: 24350726
[TBL] [Abstract][Full Text] [Related]
20. BMP signaling and its paradoxical effects in tumorigenesis and dissemination.
Zhang L; Ye Y; Long X; Xiao P; Ren X; Yu J
Oncotarget; 2016 Nov; 7(47):78206-78218. PubMed ID: 27661009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
